Asensus Surgical, Inc. TRXC
$ 4.08
-10.13%
Asensus Surgical, Inc. Financial Statements 2011-2024 | TRXC
Annual Financial Statements Asensus Surgical, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
210 M | 23.6 M | 574 M | 265 M | 166 M | 220 M | 174 M | 104 M | 18.5 M | 18.2 M |
Shares |
70.8 M | 17.7 M | 15.9 M | 11.4 M | 8.63 M | 6.13 M | 4.52 M | 979 K | 711 K | 431 K |
Net Income |
-59.3 M | -154 M | -61.8 M | -145 M | -120 M | -46.9 M | -37.7 M | -28.4 M | -6.72 M | -5.76 M |
Revenue |
3.18 M | 8.53 M | 24.1 M | 7.11 M | 1.52 M | - | 401 K | 1.43 M | 35 K | - |
EBITDA |
-45.8 M | -81.4 M | -53.5 M | -51.4 M | -48.8 M | -40.4 M | -35.3 M | -20.8 M | -6.49 M | -5.53 M |
Operating Expenses |
54.6 M | 79.5 M | 72.3 M | 59.7 M | 56.2 M | 42.5 M | 35.9 M | 18.9 M | 6.31 M | 5.67 M |
General and Administrative Expenses |
14.1 M | 18.8 M | 13.9 M | 12.3 M | 10.8 M | 7.83 M | 6.24 M | 4.22 M | - | - |
All numbers in USD currency